The Importance of Imaging in the Treatment of Alsheimer's Disease

In june, the f da gave marketing approval to biogen for agehom an anabody that aims to reduce ameloid plaxs in the brain. Abnormalities associated with t e new treatments includes brainadema and hemorrhage. And it's important for radiologists to know if a patient with these findings are on this drug. imaging is the only way to know what's wrong with them when they present with headache, altermental status and focal neurlogic deficits.